Drug-eluting stents in the elderly.

Area of Science:

• Cardiology
• Geriatric Medicine
• Interventional Cardiology

Background:

• Drug-eluting stents (DES) have transformed coronary artery disease management since 2003.
• Older adults face the highest burden of coronary artery disease and poorer outcomes.
• The use of DES in the elderly population presents unique challenges, particularly regarding bleeding risks associated with dual-antiplatelet therapy.

Purpose of the Study:

• To review the current literature on the effectiveness and safety of DES in elderly patients.
• To evaluate the risk-benefit profile of DES compared to bare metal stents in older adults.
• To address the controversy surrounding DES use in the elderly, considering age-related bleeding risks.

Main Methods:

• Systematic review of existing literature on DES therapy in elderly patients.
• Analysis of trial data and real-world evidence regarding DES use in older adults.
• Comparison of safety and efficacy outcomes between DES and bare metal stents in the elderly population.

Main Results:

• Trial data suggest a benefit of DES in elderly patients, but generalizability is limited due to exclusion criteria.
• Dual-antiplatelet therapy post-DES poses increased bleeding risks in older individuals.
• Newer antiplatelet agents may further elevate bleeding risks in this demographic.

Conclusions:

• The balance between DES efficacy and safety in elderly patients requires further clarification.
• Increased focus on the specific needs and risks of older adults undergoing DES implantation is warranted.
• As the population ages, understanding and optimizing DES therapy for the elderly is of growing importance.